India

Om Pharmaceutical Industries

API & Intermediates Manufacturers with exports to >30 countries

INDIA India

Contact Supplier

Virtual Booth

Virtual Innovation Day

Participation Not Confirmed

Update your events

Om Pharma and Astrazeneca Enter Into Strategic Collaboration to Expand Presence in Respiratory and Immunology Fields in China

Lead Product(s): Bacterial Lysates

Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: Broncho-Vaxom

Highest Development Status: Approved Product Type: Large molecule

Partner/Sponsor/Collaborator: AstraZeneca PLC

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration November 06, 2020

Details:

AstraZeneca granted an exclusive right to import and distribute the immunological therapy Broncho-Vaxom® for the prevention and treatment of respiratory tract infections in China (excluding Hong Kong, Macau, and Taiwan).

Cipla

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

INDIA India

Post An Enquiry

Virtual Booth

Virtual Innovation Day

Participation Not Confirmed

Update your events

Cipla Receives Final Approval for Generic Version Of Sunovion Pharmaceuticals, Inc.'s Brovana®

Lead Product(s): Arformoterol Tartrate

Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: Undisclosed

Highest Development Status: Approved Product Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable June 23, 2021

Details:

Cipla’s Arformoterol Tartrate Inhalation Solution 15 mcg / 2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana®.